Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cellsChih-Ta Chen, Lu‐Ping Chow|Experimental & Molecular Medicine|2020Cited by 26